A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
  • Published Date:

    Apr 11 2013

  • Source:
    PLoS Negl Trop Dis. 2013; 7(4).

You May Also Like:

  1. Filetype[PDF - 35.30 KB]
    Corporate Authors:
    Center for Global Health (U.S.). Rotary International.
    Published Date:
    August 5, 2015
    Description:
    Wuchereria bancrofti is one of the parasites that causes the painful, infectious disease.Human Stages:1. Mosquito takes a blood meal (L3 larvae enter skin)2. Adults in lymphatics3. Adults produce sheathed microfilariae that migrate into lymph and blo...
    File Type:
    Filetype[PDF - 35.30 KB]
  2. Filetype[PDF - 165.66 KB]
    Personal Author:
    Addiss, David G.; Louis-Charles, Jacky; Roberts, Jacquelin; LeConte, Frederic; Wendt, Joyanna M.; Milord, Marie Denise; Lammie, Patrick J.; Dreyer, Gerusa;
    Published Date:
    Apr 20 2010
    Source:
    PLoS Negl Trop Dis. 4(4).
    Description:
    BackgroundApproximately 14 million persons living in areas endemic for lymphatic filariasis have lymphedema of the leg. Clinical studies indicate that repeated episodes of bacterial acute dermatolymphangioadenitis (ADLA) lead to progression of lymphe...
    File Type:
    Filetype[PDF - 165.66 KB]
  3. Filetype[PDF - 206.40 KB]
    Personal Author:
    Chu, Brian K.; Deming, Michael; Biritwum, Nana-Kwadwo; Bougma, Windtaré R.; Dorkenoo, Améyo M.; El-Setouhy, Maged; Fischer, Peter U.; Gass, Katherine; Gonzalez de Peña, Manuel; Mercado-Hernandez, Leda; Kyelem, Dominique; Lammie, Patrick J.; Flueckiger, Rebecca M.; Mwingira, Upendo J.; Noordin, Rahmah; Offei Owusu, Irene; Ottesen, Eric A.; Pavluck, Alexandre; Pilotte, Nils; Rao, Ramakrishna U.; Samarasekera, Dilhani; Schmaedick, Mark A.; Settinayake, Sunil; Simonsen, Paul E.; Supali, Taniawati; Taleo, Fasihah; Torres, Melissa; Weil, Gary J.; Won, Kimberly Y.;
    Published Date:
    Dec 05 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(12).
    Description:
    BackgroundLymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate endpo...
    File Type:
    Filetype[PDF - 206.40 KB]
  4. Filetype[PDF - 93.33 KB]
    Personal Author:
    Grady, Caroline A.; Beau de Rochars, Madsen; Direny, Abdel N.; Orelus, Jean Nicolas; Wendt, Joyanna; Radday, Jeanne; Mathieu, Els; Roberts, Jacquelin M.; Streit, Thomas G.; Addiss, David G.; Lammie, Patrick J.;
    Published Date:
    Apr 2007
    Source:
    Emerg Infect Dis. 13(4):608-610.
    Description:
    In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates w...
    File Type:
    Filetype[PDF - 93.33 KB]
  5. Filetype[PDF - 467.46 KB]
    Corporate Authors:
    Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.
    Published Date:
    July 2014
    Description:
    To date, close to 700 million individuals in some of the poorest areas globally have received treatment to prevent one of the world’s most incapacitating diseases, lymphatic filariasis.Lymphatic filariasis (LF) is a disabling parasitic disease caus...
    File Type:
    Filetype[PDF - 467.46 KB]